|
⚲
|
| Keyboard |
| Lewis Karen
✚
|
|
|---|---|
| CIK # | 0001814304 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001814304] | |
| 4 | [0001814304] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Lewis Karen | |
| Apellis Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2025-01-29 | Sell | 364 | $29.52 | 10,745 |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2025-01-22 | Sell | 1,751 | $30.43 | 53,283 |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2025-01-21 | Grant | 28,508 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2025-01-17 | Sell | 1,241 | $29.96 | 37,180 |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2025-01-13 | Sell | 1,599 | $28.70 | 45,891 |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2024-01-30 | Sell | 883 | $65.53 | 57,863 |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2024-01-29 | Sell | 367 | $64.14 | 23,539 |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2024-01-23 | Sell | 4,286 | $63.69 | 272,975 |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2024-01-22 | Sell | 1,738 | $65.00 | 112,970 |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2024-01-17 | Sell | 3,276 | $65.58 | 214,840 |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2024-01-16 | Sell | 1,632 | $66.81 | 109,034 |
|
Apellis Pharmaceuticals Inc APLS
Stock Option (Right to Buy) · derivative
|
2024-01-16 | Grant | 24,666 | $66.30 | 1,635,356 |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2024-01-16 | Grant | 16,963 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2023-06-01 | Sell | 5,000 | $86.00 | 430,000 |
|
Apellis Pharmaceuticals Inc APLS
Stock Option (Right to Buy) · derivative
|
2023-06-01 | Option exercise | 5,000 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2023-06-01 | Option exercise | 5,000 | $34.11 | 170,550 |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2023-04-03 | Option exercise | 5,000 | $34.11 | 170,550 |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2023-04-03 | Sell | 5,000 | $75.00 | 375,000 |
|
Apellis Pharmaceuticals Inc APLS
Stock Option (Right to Buy) · derivative
|
2023-04-03 | Option exercise | 5,000 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2023-02-23 | Sell | 1,104 | $68.76 | 75,911 |
| showing 20 of 38 most recent transactions | |||||